| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.35 | 1e-07 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |